Comirnaty Evropska unija - slovenščina - EMA (European Medicines Agency)

comirnaty

biontech manufacturing gmbh - single-stranded, 5’-capped messenger rna produced using a cell-free in vitro transcription from the corresponding dna templates, encoding the viral spike (s) protein of sars-cov-2 - covid-19 virus infection - cepiva - comirnaty 30 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older.  comirnaty 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older.  comirnaty 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years.  comirnaty 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years.  comirnaty original/omicron ba. 1 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older who have previously received at least a primary vaccination course against covid-19. comirnaty original/omicron ba. 4-5 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years.  comirnaty original/omicron ba. 4-5 (1. 5/1. 5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years.  comirnaty omicron xbb. 5 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty omicron xbb. 5 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 10 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years. uporaba tega cepiva mora biti v skladu z uradnimi priporočili.

Armisarte (previously Pemetrexed Actavis) Evropska unija - slovenščina - EMA (European Medicines Agency)

armisarte (previously pemetrexed actavis)

actavis group ptc ehf - pemetreksedni diacid monohidrat - carcinoma, non-small-cell lung; mesothelioma - antineoplastična sredstva - maligni pleural mesotheliomapemetrexed v kombinaciji z cisplatin je primerna za zdravljenje kemoterapija naivna bolnikih z unresectable maligni pleural mesothelioma. non-small cell lung cancerpemetrexed v kombinaciji z cisplatin je označen za prvo linijo zdravljenja bolnikov z lokalno napredno ali metastatskim non-small cell lung cancer razen pretežno skvamoznih celic histologija. pemetrexed je označen kot monotherapy za vzdrževanje zdravljenje lokalno napredno ali metastatskim non-small cell lung cancer razen pretežno skvamoznih celic histologijo pri bolnikih, katerih bolezen ni napredovala takoj po platinum, ki temelji kemoterapijo. pemetrexed je označen kot monotherapy na drugi liniji zdravljenja bolnikov z lokalno napredno ali metastatskim non-small cell lung cancer razen pretežno skvamoznih celic histologija.

Xromi Evropska unija - slovenščina - EMA (European Medicines Agency)

xromi

nova laboratories ireland limited - hidroksikarbamid - anemija, srčna celica - antineoplastična sredstva - preprečevanje vaso-okluzivni zapletov anemija srpastih celic bolezni pri bolnikih nad 2 leti starosti.

Tapidola 100 mg/25 mg/200 mg filmsko obložene tablete Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

tapidola 100 mg/25 mg/200 mg filmsko obložene tablete

stada arzneimittel ag - karbidopa; levodopa; entakapon - filmsko obložena tableta - karbidopa 25 mg / 1 tableta  levodopa100 mg / 1 tableta  entakapon200 mg / 1 tableta; levodopa 100 mg / 1 tableta  entakapon200 mg / 1 tableta; entakapon 200 mg / 1 tableta - levodopa, zaviralec dekarboksilaze in zaviralec comt

Tapidola 125 mg/31,25 mg/200 mg filmsko obložene tablete Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

tapidola 125 mg/31,25 mg/200 mg filmsko obložene tablete

stada arzneimittel ag - karbidopa; levodopa; entakapon - filmsko obložena tableta - karbidopa 31,25 mg / 1 tableta  levodopa125 mg / 1 tableta  entakapon200 mg / 1 tableta; levodopa 125 mg / 1 tableta  entakapon200 mg / 1 tableta; entakapon 200 mg / 1 tableta - levodopa, zaviralec dekarboksilaze in zaviralec comt

Tapidola 150 mg/37,5 mg/200 mg filmsko obložene tablete Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

tapidola 150 mg/37,5 mg/200 mg filmsko obložene tablete

stada arzneimittel ag - karbidopa; levodopa; entakapon - filmsko obložena tableta - karbidopa 37,5 mg / 1 tableta  levodopa150 mg / 1 tableta  entakapon200 mg / 1 tableta; levodopa 150 mg / 1 tableta  entakapon200 mg / 1 tableta; entakapon 200 mg / 1 tableta - levodopa, zaviralec dekarboksilaze in zaviralec comt

Tapidola 200 mg/50 mg/200 mg filmsko obložene tablete Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

tapidola 200 mg/50 mg/200 mg filmsko obložene tablete

stada arzneimittel ag - karbidopa; levodopa; entakapon - filmsko obložena tableta - karbidopa 50 mg / 1 tableta  levodopa200 mg / 1 tableta  entakapon200 mg / 1 tableta; levodopa 200 mg / 1 tableta  entakapon200 mg / 1 tableta; entakapon 200 mg / 1 tableta - levodopa, zaviralec dekarboksilaze in zaviralec comt

Tapidola 50 mg/12,5 mg/200 mg filmsko obložene tablete Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

tapidola 50 mg/12,5 mg/200 mg filmsko obložene tablete

stada arzneimittel ag - karbidopa; levodopa; entakapon - filmsko obložena tableta - karbidopa 12,5 mg / 1 tableta  levodopa50 mg / 1 tableta  entakapon200 mg / 1 tableta; levodopa 50 mg / 1 tableta  entakapon200 mg / 1 tableta; entakapon 200 mg / 1 tableta - levodopa, zaviralec dekarboksilaze in zaviralec comt

Tapidola 75 mg/18,75 mg/200 mg filmsko obložene tablete Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

tapidola 75 mg/18,75 mg/200 mg filmsko obložene tablete

stada arzneimittel ag - karbidopa; levodopa; entakapon - filmsko obložena tableta - karbidopa 18,75 mg / 1 tableta  levodopa75 mg / 1 tableta  entakapon200 mg / 1 tableta; levodopa 75 mg / 1 tableta  entakapon200 mg / 1 tableta; entakapon 200 mg / 1 tableta - levodopa, zaviralec dekarboksilaze in zaviralec comt

Acetilsalicilna kislina Krka 100 mg gastrorezistentne tablete Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

acetilsalicilna kislina krka 100 mg gastrorezistentne tablete

krka, d.d., novo mesto - acetilsalicilna kislina - gastrorezistentna tableta - acetilsalicilna kislina 100 mg / 1 tableta - acetilsalicilna kislina